Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMIRA Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q2 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2025 | 1 | -$0.18 | -$0.18 | -$0.18 |
MIRA Pharmaceuticals, Inc. Earnings Date And Information
MIRA Pharmaceuticals, Inc. last posted its earnings results on Wednesday, February 26th, 2025. The company reported $-0.235 earnings per share for the quarter, missing analysts' consensus estimates of $-0.18 by $0.055. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MIRA Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.65 diluted earnings per share) and currently has a price-to-earnings ratio of -1.34. MIRA Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
MIRA Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.18 | -$0.14 | 0.04 | $0 | $0 |
| 08/16/2024 | Q2 2024 | N/A | -$0.11 | N/A | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.10 | -$0.09 | 0.01 | N/A | $0 |
| 04/01/2024 | Q4 2023 | -$0.23 | -$0.39 | -0.16 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.24 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.09 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.09 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$43.86 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.12 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$0.16 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.10 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MIRA Pharmaceuticals, Inc. Earnings: FAQ's
MIRA Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for MIRA Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for MIRA Pharmaceuticals, Inc.'s latest earnings report can be read online.
MIRA Pharmaceuticals, Inc. (:MIRA) has a recorded net income of $-11,982,343.MIRA Pharmaceuticals, Inc. has generated $-0.65 earnings per share over the last four quarters.
MIRA Pharmaceuticals, Inc. (:MIRA) has a price-to-earnings ratio of -1.34 and price/earnings-to-growth ratio is -0.11.